Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Relationships Between Course Capture Systems and Student Performance in Dental Hygiene Education.

Havner CJ, Gerkovich MM, Bray KK, Voelker MA.

J Dent Hyg. 2018 Oct;92(5):6-13.

PMID:
30385596
2.

Bolstering diagnostic reasoning skills with adaptive learning.

Huffman M, Gustafson S, Chatterjee S, Rabner M, Nundy S, Gerkovich MM, Wright SM.

Med Teach. 2018 Aug;40(8):845-849. doi: 10.1080/0142159X.2018.1484561. Epub 2018 Aug 9.

PMID:
30091646
3.

Cesarean Delivery with External Negative Pressure Dressing System: A Retrospective Cohort Study.

Orth TA, Gerkovich MM, Heitmann E, Overcash J, Gibbs C, Parrish M.

Surg J (N Y). 2016 Jul 20;2(3):e59-e65. doi: 10.1055/s-0036-1585470. eCollection 2016 Jul.

4.

Environmental Tobacco Smoke and Periodontitis in United States Non-Smokers, 2009 to 2012.

Sutton JD, Salas Martinez ML, Gerkovich MM.

J Periodontol. 2017 Jun;88(6):565-574. doi: 10.1902/jop.2017.160725. Epub 2017 Feb 7.

PMID:
28168902
5.

A Qualitative Description of HIV-Infected African American Women's Experiences of Psychological Distress and Their Coping Strategies.

Peltzer JN, Ogawa L, Tusher S, Farnan R, Gerkovich MM.

J Assoc Nurses AIDS Care. 2017 Mar - Apr;28(2):226-237. doi: 10.1016/j.jana.2016.09.010. Epub 2016 Oct 1.

PMID:
27771179
6.

Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies.

De A, Maulik D, Lankachandra K, Mundy DC, Ye SQ, Gerkovich MM.

J Matern Fetal Neonatal Med. 2016 Nov;29(21):3421-8. doi: 10.3109/14767058.2015.1136282. Epub 2016 Mar 3.

PMID:
26752164
7.

Down-regulation of placental neuropilin-1 in fetal growth restriction.

Maulik D, De A, Ragolia L, Evans J, Grigoryev D, Lankachandra K, Mundy D, Muscat J, Gerkovich MM, Ye SQ.

Am J Obstet Gynecol. 2016 Feb;214(2):279.e1-279.e9. doi: 10.1016/j.ajog.2015.09.068. Epub 2015 Sep 26.

8.

Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial.

Wilson D, Goggin K, Williams K, Gerkovich MM, Gqaleni N, Syce J, Bartman P, Johnson Q, Folk WR.

PLoS One. 2015 Jul 17;10(7):e0128522. doi: 10.1371/journal.pone.0128522. eCollection 2015.

9.
10.

A randomized controlled trial examining the efficacy of motivational counseling with observed therapy for antiretroviral therapy adherence.

Goggin K, Gerkovich MM, Williams KB, Banderas JW, Catley D, Berkley-Patton J, Wagner GJ, Stanford J, Neville S, Kumar VK, Bamberger DM, Clough LA.

AIDS Behav. 2013 Jul;17(6):1992-2001. doi: 10.1007/s10461-013-0467-3.

11.

Nonengagement in HIV care: a descriptive and qualitative study in hospitalized patients and community-based analysis.

Rao KC, Enriquez M, Gantt TC, Gerkovich MM, Bonham AJ, Griffin RG, Bamberger DM.

J Int Assoc Provid AIDS Care. 2013 May-Jun;12(3):178-84. doi: 10.1177/2325957412472058. Epub 2013 Feb 26.

PMID:
23442561
12.

The association of complementary and alternative medicine use and health care expenditures for back and neck problems.

Martin BI, Gerkovich MM, Deyo RA, Sherman KJ, Cherkin DC, Lind BK, Goertz CM, Lafferty WE.

Med Care. 2012 Dec;50(12):1029-36. doi: 10.1097/MLR.0b013e318269e0b2.

13.

Effect of risk adjustment method on comparisons of health care utilization between complementary and alternative medicine users and nonusers.

Lind BK, Gerkovich MM, Cherkin DC, Deyo RA, Sherman KJ, Lafferty WE.

J Altern Complement Med. 2013 Mar;19(3):250-6. doi: 10.1089/acm.2011.0707. Epub 2012 Oct 4.

14.

Outcomes from a mentored research boot camp: Focused Investigator Training (FIT) Program.

Marinac JS, Gerkovich MM.

Pharmacotherapy. 2012 Sep;32(9):792-8. doi: 10.1002/j.1875-9114.2012.01113.x. Epub 2012 Jul 31.

PMID:
22851412
15.

Do coping styles mediate the relationship between substance use and educational attainment and antiretroviral adherence?

Martinez DA, Goggin K, Catley D, Gerkovich MM, Williams K, Wright J, Berkley-Patton J; MOTIV8.

AIDS Behav. 2012 Nov;16(8):2319-29. doi: 10.1007/s10461-012-0222-1.

16.

Complex factors in the etiology of Gulf War illness: wartime exposures and risk factors in veteran subgroups.

Steele L, Sastre A, Gerkovich MM, Cook MR.

Environ Health Perspect. 2012 Jan;120(1):112-8. doi: 10.1289/ehp.1003399. Epub 2011 Sep 19.

17.

Autonomous regulation and locus of control as predictors of antiretroviral medication adherence.

Lynam I, Catley D, Goggin K, Rabinowitz JL, Gerkovich MM, Williams K, Wright J; MOTIV8.

J Health Psychol. 2009 May;14(4):578-86. doi: 10.1177/1359105309103577.

18.

Effects of the nicotine patch on performance during the first week of smoking cessation.

Cook MR, Gerkovich MM, Graham C, Hoffman SJ, Peterson RC.

Nicotine Tob Res. 2003 Apr;5(2):169-80. Review.

PMID:
12745489
19.

Human EEG responses to controlled alterations of the Earth's magnetic field.

Sastre A, Graham C, Cook MR, Gerkovich MM, Gailey P.

Clin Neurophysiol. 2002 Sep;113(9):1382-90.

PMID:
12169319
20.

Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study.

Cook MR, Graham C, Sastre A, Gerkovich MM.

Psychopharmacology (Berl). 2002 Jul;162(2):186-92. Epub 2002 May 1.

PMID:
12110996
21.

The effect of anticipatory strategies on the first day of smoking cessation.

O'Connell KA, Gerkovich MM, Bott MJ, Cook MR, Shiffman S.

Psychol Addict Behav. 2002 Jun;16(2):150-6.

PMID:
12079254
22.

Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition.

Cook MR, Gerkovich MM, Sastre A, Graham C.

Aviat Space Environ Med. 2001 Dec;72(12):1102-6.

PMID:
11763111
23.

All-night exposure to EMF does not alter urinary melatonin, 6-OHMS or immune measures in older men and women.

Graham C, Sastre A, Cook MR, Gerkovich MM.

J Pineal Res. 2001 Sep;31(2):109-13.

PMID:
11555165
24.

Melatonin and 6-OHMS in high-intensity magnetic fields.

Graham C, Cook MR, Gerkovich MM, Sastre A.

J Pineal Res. 2001 Aug;31(1):85-8.

PMID:
11485010
25.

Examination of the melatonin hypothesis in women exposed at night to EMF or bright light.

Graham C, Cook MR, Gerkovich MM, Sastre A.

Environ Health Perspect. 2001 May;109(5):501-7. Erratum in: Environ Health Perspect 2001 Jul;109(7):A304.

26.

Reliability and validity of the Overeating Tension Scale.

Popkess-Vawter S, Gerkovich MM, Wendel S.

J Nurs Meas. 2000 Fall-Winter;8(2):145-60.

PMID:
11227581
27.

Nocturnal magnetic field exposure: gender-specific effects on heart rate variability and sleep.

Graham C, Sastre A, Cook MR, Gerkovich MM.

Clin Neurophysiol. 2000 Nov;111(11):1936-41.

PMID:
11068226
28.

Exposure to strong ELF magnetic fields does not alter cardiac autonomic control mechanisms.

Graham C, Sastre A, Cook MR, Kavet R, Gerkovich MM, Riffle DW.

Bioelectromagnetics. 2000 Sep;21(6):413-21.

PMID:
10972945
29.

Cardiac autonomic control mechanisms in power-frequency magnetic fields: a multistudy analysis.

Graham C, Cook MR, Sastre A, Gerkovich MM, Kavet R.

Environ Health Perspect. 2000 Aug;108(8):737-42.

30.

Multi-night exposure to 60 Hz magnetic fields: effects on melatonin and its enzymatic metabolite.

Graham C, Cook MR, Sastre A, Riffle DW, Gerkovich MM.

J Pineal Res. 2000 Jan;28(1):1-8.

PMID:
10626595
31.

Human exposure to 60-Hz magnetic fields: neurophysiological effects.

Graham C, Cook MR, Cohen HD, Riffle DW, Hoffman S, Gerkovich MM.

Int J Psychophysiol. 1999 Aug;33(2):169-75.

PMID:
10489081
32.

Coping in real time: using Ecological Momentary Assessment techniques to assess coping with the urge to smoke.

O'Connell KA, Gerkovich MM, Cook MR, Shiffman S, Hickcox M, Kakolewski KE.

Res Nurs Health. 1998 Dec;21(6):487-97.

PMID:
9839794
33.

Effects of smoking and telic/paratelic dominance on the contingent negative variation (CNV).

Cook MR, Gerkovich MM, Hoffman SJ, McClernon FJ, O'Connell KA.

Int J Psychophysiol. 1996 Aug-Sep;23(1-2):101-10.

PMID:
8880370
34.

Nocturnal melatonin levels in human volunteers exposed to intermittent 60 Hz magnetic fields.

Graham C, Cook MR, Riffle DW, Gerkovich MM, Cohen HD.

Bioelectromagnetics. 1996;17(4):263-73.

PMID:
8891185
35.

Reversal theory constructs and cigarette availability predict lapse early in smoking cessation.

Cook MR, Gerkovich MM, O'Connell KA, Potocky M.

Res Nurs Health. 1995 Jun;18(3):217-24.

PMID:
7754092
36.

Smoking and EEG power spectra: effects of differences in arousal seeking.

Cook MR, Gerkovich MM, Hoffman SJ, McClernon FJ, Cohen HD, Oakleaf KL, O'Connell KA.

Int J Psychophysiol. 1995 Apr;19(3):247-56.

PMID:
7558991
37.

Reversal theory's mastery and sympathy states in smoking cessation.

O'Connell KA, Gerkovich MM, Cook MR.

Image J Nurs Sch. 1995 Winter;27(4):311-6.

PMID:
8530121
38.

Dose response study of human exposure to 60 Hz electric and magnetic fields.

Graham C, Cook MR, Cohen HD, Gerkovich MM.

Bioelectromagnetics. 1994;15(5):447-63.

PMID:
7802712
39.

Instruments for the assessment of reversal theory states.

Cook MR, Gerkovich MM, Potocky M, O'Connell KA.

Patient Educ Couns. 1993 Dec;22(2):99-106. No abstract available.

PMID:
8153032
40.

Reversal theory analysis of relapse crises following smoking cessation.

Gerkovich MM, Cook MR, O'Connell KA, Potocky M.

Patient Educ Couns. 1993 Dec;22(2):91-7. No abstract available.

PMID:
8153031
41.

A replication study of human exposure to 60-Hz fields: effects on neurobehavioral measures.

Cook MR, Graham C, Cohen HD, Gerkovich MM.

Bioelectromagnetics. 1992;13(4):261-85.

PMID:
1510736
42.

Effects of methanol vapor on human neurobehavioral measures.

Cook MR, Bergman FJ, Cohen HD, Gerkovich MM, Graham C, Harris RK, Siemann LG.

Res Rep Health Eff Inst. 1991 Aug;(42):1-45.

PMID:
1930768
43.

State-outcome consistency in smoking relapse crises: a reversal theory approach.

Potocky M, Gerkovich MM, O'Connell KA, Cook MR.

J Consult Clin Psychol. 1991 Apr;59(2):351-3.

PMID:
2030199
44.

Reversal theory and smoking: a state-based approach to ex-smokers' highly tempting situations.

O'Connell KA, Cook MR, Gerkovich MM, Potocky M, Swan GE.

J Consult Clin Psychol. 1990 Aug;58(4):489-94.

PMID:
2212187
45.

Measurement of salivary thiocyanate during the process of smoking cessation.

Gerkovich MM, O'Connell KA, Fears BA, Cook MR.

J Subst Abuse. 1990;2(1):69-75.

PMID:
2136104
46.

The influence of salivary stimulation on the validity of thiocyanate as an index of smoking status.

O'Connell KA, Gerkovich MM, Fears BA, Cook MR.

Addict Behav. 1988;13(4):383-6.

PMID:
3239470
47.

Evaluation of salivary thiocyanate as an indicator of smoking behavior.

Fears BA, Gerkovich MM, O'Connell KA, Cook MR.

Health Psychol. 1987;6(6):561-8.

PMID:
3691454
48.

Effects of variation in physical effort on frontalis EMG activity.

Graham C, Cook MR, Cohen HD, Gerkovich MM, Phelps JW, Fotopoulos SS.

Biofeedback Self Regul. 1986 Jun;11(2):135-41.

PMID:
3567233
49.

Use of the McGill pain questionnaire in the assessment of cancer pain: replicability and consistency.

Graham C, Bond SS, Gerkovich MM, Cook MR.

Pain. 1980 Jun;8(3):377-87.

PMID:
7402695

Supplemental Content

Loading ...
Support Center